13 December 2017 in Nephrology Dialysis Transplantation
Chronic kidney disease (CKD) patients have deficient levels of glutathione peroxidase-3 (GPx3). We hypothesized that GPx3 deficiency may lead to cardiovascular disease in the presence of chronic kidney disease due to an accumulation of reactive oxygen species and decreased microvascular perfusion of the myocardium. To isolate the exclusive effect of GPx3 deficiency in kidney disease–induced cardiac disease, we studied the GPx3 knockout mouse strain (GPx3−/−) in the setting of surgery-induced CKD. Ribonucleic acid (RNA) microarray screening of non-stimulated GPx3−/− heart tissue show increased expression of genes associated with cardiomyopathy including myh7, plac9, serpine1 and cd74 compared with wild-type (WT) controls. GPx3−/− mice underwent surgically induced renal mass reduction to generate a model of CKD. GPx3−/− + CKD mice underwent echocardiography 4 weeks after injury. Fractional shortening (FS) was decreased to 32.9 ± 5.8% in GPx3−/− + CKD compared to 62.0% ± 10.3 in WT + CKD (P < 0.001). Platelet aggregates were increased in the myocardium of GPx3−/− + CKD. Asymmetric dimethylarginine (ADMA) levels were increased in both GPx3−/− + CKD and WT+ CKD. ADMA stimulated spontaneous platelet aggregation more quickly in washed platelets from GPx3−/−. In vitro platelet aggregation was enhanced in samples from GPx3−/− + CKD. Platelet aggregation in GPx3−/− + CKD samples was mitigated after in vivo administration of ebselen, a glutathione peroxidase mimetic. FS improved in GPx3−/− + CKD mice after ebselen treatment. These results suggest GPx3 deficiency is a substantive contributing factor to the development of kidney disease–induced cardiac disease.
31 October 2022 in Journal of the American Society of Nephrology
Significance Statement: Extreme stress, such as life-threatening sepsis, triggers the integrated stress response and causes translation shutdown, a hallmark of late-phase, sepsis-induced kidney injury. Although a brief period of translation shutdown could be cytoprotective, prolonged translation repression can have negative consequences and has been shown to contribute to sepsis-induced kidney failure. Using a murine model of endotoxemia, the authors show that the duration of stress-induced translation shutdown in the kidney can be shortened by overexpressing protein phosphatase 1 regulatory subunit 15A (Ppp1r15a, also known as GADD34), a key regulator of the translation initiation complex. They achieved overexpression of Ppp1r15a with genetic and oligonucleotide approaches, targeting its upstream open reading frame (uORF). Altering Ppp1r15a expression through its uORF to counter translation shutdown offers a potential strategy for the treatment of sepsis-induced kidney failure. Background: Translation shutdown is a hallmark of late-phase, sepsis-induced kidney injury. Methods for controlling protein synthesis in the kidney are limited. Reversing translation shutdown requires dephosphorylation of the eukaryotic initiation factor 2 (eIF2) subunit eIF2α; this is mediated by a key regulatory molecule, protein phosphatase 1 regulatory subunit 15A (Ppp1r15a), also known as GADD34. Methods: To study protein synthesis in the kidney in a murine endotoxemia model and investigate the feasibility of translation control in vivo by boosting the protein expression of Ppp1r15a, we combined multiple tools, including ribosome profiling (Ribo-seq), proteomics, polyribosome profiling, and antisense oligonucleotides, and a newly generated Ppp1r15a knock-in mouse model and multiple mutant cell lines. Results: We report that translation shutdown in established sepsis-induced kidney injury is brought about by excessive eIF2α phosphorylation and sustained by blunted expression of the counter-regulatory phosphatase Ppp1r15a. We determined the blunted Ppp1r15a expression persists because of the presence of an upstream open reading frame (uORF). Overcoming this barrier with genetic and antisense oligonucleotide approaches enabled the overexpression of Ppp1r15a, which salvaged translation and improved kidney function in an endotoxemia model. Loss of this uORF also had broad effects on the composition and phosphorylation status of the immunopeptidome—peptides associated with the MHC—that extended beyond the eIF2α axis. Conclusions: We found Ppp1r15a is translationally repressed during late-phase sepsis because of the existence of an uORF, which is a prime therapeutic candidate for this strategic rescue of translation in late-phase sepsis. The ability to accurately control translation dynamics during sepsis may offer new paths for the development of therapies at codon-level precision.
1 January 2017 in Kidney International
1 March 2022 in Journal of the American Heart Association
Background: The myocardial cytoskeleton functions as the fundamental framework critical for organelle function, bioenergetics and myocardial remodeling. To date, impairment of the myocardial cytoskeleton occurring in the failing heart in patients with advanced chronic kidney disease has been largely undescribed. Methods and Results: We conducted a 3‐arm cross‐sectional cohort study of explanted human heart tissues from patients who are dependent on hemodialysis (n=19), hypertension (n=10) with preserved renal function, and healthy controls (n=21). Left ventricular tissues were subjected to pathologic examination and next‐generation RNA sequencing. Mechanistic and interference RNA studies utilizing in vitro human cardiac fibroblast models were performed. Left ventricular tissues from patients undergoing hemodialysis exhibited increased myocardial wall thickness and significantly greater fibrosis compared with hypertension patients ( P <0.05) and control ( P <0.01). Transcriptomic analysis revealed that the focal adhesion pathway was significantly enriched in hearts from patients undergoing hemodialysis. Hearts from patients undergoing hemodialysis exhibited dysregulated components of the focal adhesion pathway including reduced β‐actin ( P <0.01), β‐tubulin ( P <0.01), vimentin ( P <0.05), and increased expression of vinculin ( P <0.05) compared with controls. Cytoskeletal adaptations in hearts from the hemodialysis group were associated with impaired mitochondrial bioenergetics, including dysregulated mitochondrial dynamics and fusion, and loss of cell survival pathways. Mechanistic studies revealed that cytoskeletal changes can be driven by uremic and metabolic abnormalities of chronic kidney disease, in vitro. Furthermore, focal adhesion kinase silencing via interference RNA suppressed major cytoskeletal proteins synergistically with mineral stressors found in chronic kidney disease in vitro. Conclusions: Myocardial failure in advanced chronic kidney disease is characterized by impairment of the cytoskeleton involving disruption of the focal adhesion pathway, mitochondrial failure, and loss of cell survival pathways.